Illumina, Inc. (ILMN)
NASDAQ · Healthcare
Illumina, Inc. EBITDA 2008–2025
Illumina, Inc. annual/quarterly ebitda history and growth rate from 2014 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Illumina, Inc. ebitda for the quarter ending September 28, 2025 was 294.0 M, a 63.75% decrease year-over-year.
- Illumina, Inc. ebitda for the twelve months ending September 28, 2025 was 1.6 B, a 189.65% decrease year-over-year.
- Illumina, Inc. annual ebitda for 2025 was 1.1 B, a 324.84% decrease from 2024.
- Illumina, Inc. annual ebitda for 2024 was -479.0 M, a 24.80% decrease from 2023.
- Illumina, Inc. annual ebitda for 2023 was -637.0 M, a 83.17% decrease from 2023.
- Illumina, Inc. annual ebitda for 2023 was -3.8 B.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Illumina, Inc. EBITDA — FAQ
Illumina, Inc. (ILMN) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ILMN's ebitda history?
The chart and table above show Illumina, Inc.'s ebitda by year and by quarter, including the growth rate.